Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Use of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections.

NCT04306731 is registered in ClinicalTrials.gov with University of Sulaimani as lead sponsor.

NCT NCT04306731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04306731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Use of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections.
Lead sponsor
University of Sulaimani
Phase
Not applicable
Overall status
Completed
Start date
September 20, 2014
Completion date
April 21, 2017
Enrollment
437 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent urinary tract infection